{"id":17763,"date":"2026-09-07T08:08:24","date_gmt":"2026-09-07T06:08:24","guid":{"rendered":"https:\/\/www.interpharma.ch\/blog\/erkenntnisse\/zahlungsbereitschaft-fuer-innovative-medikamente\/"},"modified":"2026-10-14T15:03:46","modified_gmt":"2026-10-14T13:03:46","slug":"la-population-est-prete-a-payer-davantage-pour-les-medicaments-innovants","status":"publish","type":"steuerstudie","link":"https:\/\/www.interpharma.ch\/fr\/blog\/enseignements\/la-population-est-prete-a-payer-davantage-pour-les-medicaments-innovants\/","title":{"rendered":"La population est pr\u00eate \u00e0 payer davantage pour les m\u00e9dicaments innovants."},"featured_media":17955,"menu_order":0,"template":"page-templates\/studie-investment2.php","class_list":["post-17763","steuerstudie","type-steuerstudie","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.6 (Yoast SEO v28.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>La population est pr\u00eate \u00e0 payer davantage pour les m\u00e9dicaments innovants. - Interpharma<\/title>\n<meta name=\"description\" content=\"Pour un acc\u00e8s plus large et plus rapide aux m\u00e9dicaments innovants, les Suissesses et les Suisses accepteraient des primes plus \u00e9lev\u00e9es. La population rejette clairement toute nouvelle d\u00e9gradation de l\u2019acc\u00e8s.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/la-population-est-prete-a-payer-davantage-pour-les-medicaments-innovants\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La population est pr\u00eate \u00e0 payer davantage pour les m\u00e9dicaments innovants.\" \/>\n<meta property=\"og:description\" content=\"Pour un acc\u00e8s plus large et plus rapide aux m\u00e9dicaments innovants, les Suissesses et les Suisses accepteraient des primes plus \u00e9lev\u00e9es. La population rejette clairement toute nouvelle d\u00e9gradation de l\u2019acc\u00e8s.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/la-population-est-prete-a-payer-davantage-pour-les-medicaments-innovants\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-14T13:03:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/09\/disposition-payer-medicaments-innovants-image-apercu-fr.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"627\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/erkenntnisse\\\/la-population-est-prete-a-payer-davantage-pour-les-medicaments-innovants\\\/\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/erkenntnisse\\\/la-population-est-prete-a-payer-davantage-pour-les-medicaments-innovants\\\/\",\"name\":\"La population est pr\u00eate \u00e0 payer davantage pour les m\u00e9dicaments innovants. - Interpharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/erkenntnisse\\\/la-population-est-prete-a-payer-davantage-pour-les-medicaments-innovants\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/erkenntnisse\\\/la-population-est-prete-a-payer-davantage-pour-les-medicaments-innovants\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/disposition-payer-medicaments-innovants-image-apercu-fr.png\",\"datePublished\":\"2026-09-07T06:08:24+00:00\",\"dateModified\":\"2026-10-14T13:03:46+00:00\",\"description\":\"Pour un acc\u00e8s plus large et plus rapide aux m\u00e9dicaments innovants, les Suissesses et les Suisses accepteraient des primes plus \u00e9lev\u00e9es. La population rejette clairement toute nouvelle d\u00e9gradation de l\u2019acc\u00e8s.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/erkenntnisse\\\/la-population-est-prete-a-payer-davantage-pour-les-medicaments-innovants\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/erkenntnisse\\\/la-population-est-prete-a-payer-davantage-pour-les-medicaments-innovants\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/erkenntnisse\\\/la-population-est-prete-a-payer-davantage-pour-les-medicaments-innovants\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/disposition-payer-medicaments-innovants-image-apercu-fr.png\",\"contentUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/disposition-payer-medicaments-innovants-image-apercu-fr.png\",\"width\":1200,\"height\":627,\"caption\":\"33 francs de plus par mois: c\u2019est ce que la population est pr\u00eate \u00e0 payer pour avoir acc\u00e8s au m\u00eame nombre de m\u00e9dicaments innovants qu\u2019en Allemagne. Source: Swiss Economics sur mandat d\u2019Interpharma.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/erkenntnisse\\\/la-population-est-prete-a-payer-davantage-pour-les-medicaments-innovants\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Steuerstudien\",\"item\":\"https:\\\/\\\/www.interpharma.ch\\\/blog\\\/steuerstudie\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"La population est pr\u00eate \u00e0 payer davantage pour les m\u00e9dicaments innovants.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#website\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.interpharma.ch\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\",\"name\":\"Interpharma\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"contentUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"width\":\"1200\",\"height\":\"1200\",\"caption\":\"Interpharma\"},\"image\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/interpharma_ch\",\"https:\\\/\\\/ch.linkedin.com\\\/company\\\/interpharma\",\"https:\\\/\\\/www.instagram.com\\\/interpharma_ch\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"La population est pr\u00eate \u00e0 payer davantage pour les m\u00e9dicaments innovants. - Interpharma","description":"Pour un acc\u00e8s plus large et plus rapide aux m\u00e9dicaments innovants, les Suissesses et les Suisses accepteraient des primes plus \u00e9lev\u00e9es. La population rejette clairement toute nouvelle d\u00e9gradation de l\u2019acc\u00e8s.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/la-population-est-prete-a-payer-davantage-pour-les-medicaments-innovants\/","og_locale":"fr_FR","og_type":"article","og_title":"La population est pr\u00eate \u00e0 payer davantage pour les m\u00e9dicaments innovants.","og_description":"Pour un acc\u00e8s plus large et plus rapide aux m\u00e9dicaments innovants, les Suissesses et les Suisses accepteraient des primes plus \u00e9lev\u00e9es. La population rejette clairement toute nouvelle d\u00e9gradation de l\u2019acc\u00e8s.","og_url":"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/la-population-est-prete-a-payer-davantage-pour-les-medicaments-innovants\/","og_site_name":"Interpharma","article_modified_time":"2026-10-14T13:03:46+00:00","og_image":[{"width":1200,"height":627,"url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/09\/disposition-payer-medicaments-innovants-image-apercu-fr.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@interpharma_ch","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/la-population-est-prete-a-payer-davantage-pour-les-medicaments-innovants\/","url":"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/la-population-est-prete-a-payer-davantage-pour-les-medicaments-innovants\/","name":"La population est pr\u00eate \u00e0 payer davantage pour les m\u00e9dicaments innovants. - Interpharma","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/la-population-est-prete-a-payer-davantage-pour-les-medicaments-innovants\/#primaryimage"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/la-population-est-prete-a-payer-davantage-pour-les-medicaments-innovants\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/09\/disposition-payer-medicaments-innovants-image-apercu-fr.png","datePublished":"2026-09-07T06:08:24+00:00","dateModified":"2026-10-14T13:03:46+00:00","description":"Pour un acc\u00e8s plus large et plus rapide aux m\u00e9dicaments innovants, les Suissesses et les Suisses accepteraient des primes plus \u00e9lev\u00e9es. La population rejette clairement toute nouvelle d\u00e9gradation de l\u2019acc\u00e8s.","breadcrumb":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/la-population-est-prete-a-payer-davantage-pour-les-medicaments-innovants\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/la-population-est-prete-a-payer-davantage-pour-les-medicaments-innovants\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/la-population-est-prete-a-payer-davantage-pour-les-medicaments-innovants\/#primaryimage","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/09\/disposition-payer-medicaments-innovants-image-apercu-fr.png","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/09\/disposition-payer-medicaments-innovants-image-apercu-fr.png","width":1200,"height":627,"caption":"33 francs de plus par mois: c\u2019est ce que la population est pr\u00eate \u00e0 payer pour avoir acc\u00e8s au m\u00eame nombre de m\u00e9dicaments innovants qu\u2019en Allemagne. Source: Swiss Economics sur mandat d\u2019Interpharma."},{"@type":"BreadcrumbList","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/la-population-est-prete-a-payer-davantage-pour-les-medicaments-innovants\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.interpharma.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"Steuerstudien","item":"https:\/\/www.interpharma.ch\/blog\/steuerstudie\/"},{"@type":"ListItem","position":3,"name":"La population est pr\u00eate \u00e0 payer davantage pour les m\u00e9dicaments innovants."}]},{"@type":"WebSite","@id":"https:\/\/www.interpharma.ch\/#website","url":"https:\/\/www.interpharma.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.interpharma.ch\/#organization","name":"Interpharma","url":"https:\/\/www.interpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","width":"1200","height":"1200","caption":"Interpharma"},"image":{"@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/interpharma_ch","https:\/\/ch.linkedin.com\/company\/interpharma","https:\/\/www.instagram.com\/interpharma_ch\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/steuerstudie\/17763","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/steuerstudie"}],"about":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/types\/steuerstudie"}],"version-history":[{"count":9,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/steuerstudie\/17763\/revisions"}],"predecessor-version":[{"id":17973,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/steuerstudie\/17763\/revisions\/17973"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media\/17955"}],"wp:attachment":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media?parent=17763"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}